Carve-In or Carve-Out? The Future of Hospice Under Medicare Advantage | Part One

In Part One of this thought-provoking conversation, Chris Comeaux and Robin Heffernan explore the evolving intersection of private equity, artificial intelligence, and end-of-life care—raising critical questions about accountability, quality, and the future of hospice under Medicare Advantage. As the healthcare system shifts toward value-based models, the discussion challenges long-held assumptions about whether hospice should remain “carved out” or be fully integrated into payer responsibili...